CD274 and non-small cell lung carcinoma: We therefore assessed PD-L1 expression by IHC on TCs in treatment-naive diagnostic tumor samples and matched lung resections from patients with operable stage III NSCLC who were treated in the Swiss Group for Clinical Cancer Research (SAKK) trials 16/96, 16/00, 16/01, and 16/14.7